NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Autologous Platelet Enriched Gel Versus Metalloproteinase Inhibitor in the Healing of Chronic Lower Leg Ulcers

NCT00658983

CompletedNA

Sponsor: University Hospital, Ghent

Conditions: Chronic Lower Leg Ulcer

Interventions: Autologous Platelet Enriched Gel, Metalloproteinase Inhibitor

Countries: Belgium

Compare Autologous Platelet Enriched Gel versus Metalloproteinase Inhibitor in the healing of chronic lower leg ulcers.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* 18 year or older
* A non-healing chronic lower leg ulcer
* Platelet ranges of 150000 per ml circulating blood

Exclusion Criteria:

* Presence of a tumor or metastatic disease
* Hypersensitive to collagen regenerated cellulose
* Hemodynamic unstable patient
* Hypercoagulability
* Heart decompensation or angina pectoris

Locations (1)

Ghent, Belgium